Johnson Investment Counsel’s Boston Scientific BSX Stock Holding History

Johnson Investment Counsel’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Sell	4,749 -54	-1%	-$2.93K	﹤0.01%	822
2026 Q1	$301K	Sell	4,803 -1,780	-27%	-$142K	﹤0.01%	706
2025 Q4	$628K	Sell	6,583 -500	-7%	-$49K	0.01%	494
2025 Q3	$692K	Sell	7,083 -839	-11%	-$86.9K	0.01%	500
2025 Q2	$851K	Sell	7,922 -507	-6%	-$51.3K	0.01%	434
2025 Q1	$850K	Sell	8,429 -665	-7%	-$67K	0.01%	426
2024 Q4	$812K	Sell	9,094 -1,147	-11%	-$101K	0.01%	430
2024 Q3	$858K	Buy	10,241 +175	+2%	+$13.8K	0.01%	417
2024 Q2	$775K	Buy	10,066 +67	+0.7%	+$4.9K	0.01%	411
2024 Q1	$685K	Buy	+9,999	New	+$643K	0.01%	435

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Johnson Investment Counsel's BSX Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Boston Scientific (BSX) stake by 1.1% in Q2 2026, selling an estimated $2.93K and leaving 4,749 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #822.

Johnson Investment Counsel first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $858K in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Johnson Investment Counsel held 4,749 shares of Boston Scientific worth $203K as of Q2 2026.
Johnson Investment Counsel sold 54 Boston Scientific shares in Q2 2026, an estimated $2.93K.
Boston Scientific made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #822 holding.
Johnson Investment Counsel first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
Johnson Investment Counsel's Boston Scientific position peaked at $858K in Q3 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.